Adult, Children's Hospital of Philadelphia, Clinical Trials, Dr. Fleischman, Dr. Park, Dr. Phillips, Dr. Seif, Drug, Mid-Atlantic, Oncology, Pediatric, Rare Disease, Stanford University, University of California Davis, University of California Irvine, University of Michigan
Press Release: Finalists Announced for CureAccelerator Live! for Rare Diseases 2020 Competition Finalists Announced for CureAccelerator Live! for Rare Diseases 2020 Competition Virtual Pitch Event on June 11 Features 5 Clinical Repurposing Projects April 21, 2020...
Adult, Children's Hospital of Philadelphia, Clinical Trials, Dr. Fleischman, Dr. Park, Dr. Phillips, Dr. Seif, Drug, Mid-Atlantic, Oncology, Pediatric, Rare Disease, Stanford University, University of California Davis, University of California Irvine, University of Michigan
Press Release: University of California, Irvine Researcher Wins CureAccelerator Live! for Rare Diseases University of California, Irvine Researcher Wins CureAccelerator Live! for Rare Diseases Clinical Trial in Myeloproliferative Neoplasms Receives Funding to...
Adult, City of Hope, Current Research, Dr. Phillips, Drug, Minority/Underrepresented, Oncology, Rare Disease
Repurposing Venetoclax and Glofitamab to Improve Patient Response in Mantle Cell Lymphoma Principal Investigator: Dr. Tycel Phillips Disease: Mantle cell lymphoma Research Description: Mantle cell lymphoma (MCL) is a rare form of non-Hodgkin lymphoma (NHL) that is...
Adult, CureAccelerator Live!, Dr. Phillips, Drug, Minority/Underrepresented, Oncology, Rare Disease, University of Michigan
Improving Patient Response in Mantle Cell Lymphoma with Venetoclax Principal Investigator: Dr. Tycel Phillips Disease: Mantle cell lymphoma Research Description: Mantle cell lymphoma (MCL) is a rare form of non-Hodgkin lymphoma (NHL) that is diagnosed mostly in older...
